Zelgen’s ZG2001 and ZG0895 Clinical Trials Approved by NMPA
Suzhou Zelgen Biopharmaceuticals Co., Ltd (SHA: 688266) has announced that separate clinical trial filings for...
Innovent Biologics Initiates Phase II Study for IBI311 in Thyroid-Associated Ophthalmopathy
China-based Innovent Biologics Inc., (HKG: 1801) has announced the first patient dosing in a Phase...
Hygea Medtech Secures Series D Funding for Oncology Device Expansion
Hygea Medical Technology Co., Ltd, a leading minimally invasive device maker for oncology indications based...
CTI Acquires Vectoring Pharmatech to Expand Pharmacy CMC Research
China-based Centre Testing International Group Co., Ltd (CTI), a leading third-party testing and qualification services...
Shenzhen United Family Hospital Partners with GBA Medical Delegation
Shenzhen United Family Hospital has struck a partnership with a medical delegation from the Guangdong-Hong...
Vincentage Raises RMB 100 Million for Innovative Drug Development
Suzhou-based new drug developer Vincentage has reportedly raised close to RMB 100 million (USD 14.6...
Sequanta and Grandomics Collaborate on Ultra-High Throughput Sequencing Lab
Sequanta Technologies, a multi-omics research and clinical service provider based in Shanghai, and Grandomics Biosciences...
Luzhu Biotech Files for IPO in Hong Kong, Sponsored by CICC
Beijing Luzhu Biotechnology Co., Ltd, a leading human vaccine and therapeutic biologics maker, has made...
China’s NRDL Update: New Drugs Available for Online Procurement
Shanghai’s Sunshine Medical Procurement All-in-One (SMPA) drug procurement platform has released a notice stating that...
Mindray Launches First Wireless Handheld Ultrasound System, TE Air
China-based medical device firm Mindray (SHE: 300760) has announced the market launch of the firm’s...
Harbour BioMed Licenses HBM7008 to Cullinan Oncology for US Development
Harbour BioMed (HBM), which operates out of the Netherlands, the United States, and Suzhou, China,...
Kangtai Biological Begins Phase I Trial for Tetravalent Influenza Vaccine
China-based Shenzhen Kangtai Biological Products Co., Ltd (SHE: 300601) has announced the first subject enrollment...
Jiangsu Recbio Completes First Tranche Enrollment for Shingles Vaccine REC610
China-based Jiangsu Recbio Technology Co., Ltd has announced the completion of the first tranche of...
Beijing Wantai Initiates Phase I Study for 20-Valent Pneumonia Vaccine
China-based Beijing Wantai Biological Pharmacy Enterprise Co., Ltd (SHA: 603392) has announced the initiation and...
Gracell Biotechnologies Gains IND Approval for GC012F in China
Gracell Biotechnologies has reported receiving Investigational New Drug (IND) approval from the Center for Drug...
China’s Ministries Release Plan for Urban Medical Group Pilots
A group of ministries led by the National Health Commission (NHC), including the National Development...
ThinmedTech Partners with West China Hospital for CKD Digital Therapy
ThinmedTech, a chronic disease clinical management solution provider based in Chongqing, has struck a partnership...
RemeGen Gains NMPA Approval for RC48 and Pyrotinib Clinical Study
China-based RemeGen Ltd (HKG: 9995) has announced receiving the go-ahead from the National Medical Products...
Clover Biopharmaceuticals Administers First Dose of COVID-19 Vaccine SCB-2019 in Zhejiang
China-based Clover Biopharmaceuticals, Ltd (HKG: 2197) has announced the first jab of its COVID-19 vaccine...
Hengrui Pharmaceuticals Licenses SHR2554 to Treeline Biosciences
China’s Jiangsu Hengrui Pharmaceuticals (SHA: 600276) has announced a licensing agreement with US-based Treeline Biosciences,...